Navamedic ASA: Double digit growth in the 3rd quarter, 2025
Navamedic ASA: Double Digit Growth in the 3rd Quarter, 2025 Navamedic ASA (OSE: NAVA), a Nordic pharma company, reported revenues of NOK 138.9 million in the third quarter of 2025, a 12.9%…
Navamedic ASA: Double Digit Growth in the 3rd Quarter, 2025 Navamedic ASA (OSE: NAVA), a Nordic pharma company, reported revenues of NOK 138.9 million in the third quarter of 2025, a 12.9%…
OpenAI Offers Free ChatGPT Go for One Year to Indian Users OpenAI is providing its ChatGPT Go plan free of charge for one year to users in…
MSD Receives FDA Approval for Winrevair's Updated Indication MSD has received US FDA approval for an updated indication of Winrevair by in…